Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Denmark
Sweden
Finland
Norway
Latest
Trending
Followed

Sleep Cycle, Audiocast, Q3'26

By Inderes10/23/2026, 7:30 AM
Sleep Cycle

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Mikael Kågebäck
00:01 - 10:34

Good morning and welcome to Sleep Cycle's third quarter earnings call. I am Mikael Kågebäck, acting CEO and CTO. And I am joined today by Elisabeth Hedman, our CFO and Head of Investor Relations. Q3 was a quarter of record B2B revenue, a leaner organization, and we have proposed to acquire Audiowell, which shareholders will vote on at the AGM on the 11th of November. Agenda. Today I will take you through who we are and where we stand today. We will discuss the Audiowell proposal, and Elisabeth will then take us through the financials. Finally, we will conclude with a summary and take your questions. Though we live in a time of change, I think we all can agree our purpose here remains as relevant as ever. We want to help people improve global health by helping them take control of their sleep. Sleep Cycle is in a unique position that is very hard to replicate for a newcomer. We have now analyzed over 4 billion nights of sleep. We have been installed over 82 million times around the world, and we have about 2.5 million yearly active users enjoying our world-leading sleep tracking. Our sticky smart alarm and our scientifically based sleep programs. And this has all been built largely through organic growth. That data, that distribution, and more than a decade of sleep expertise are exactly what every part of our strategy builds on, because sleep is much bigger than the sleep app category. It has been increasingly recognized as a driver of health recovery, performance, and longevity, and too little sleep is linked to obesity, diabetes, and cardiovascular disease. And due to this, sleep experiences are now moving into all kinds of things: wearables, pharma, digital health, smart home, and broader health platforms. And due to this, demand is growing for passive, continuous health insights built into products people already use. And that is exactly where our technology is strongest. Sleep Cycle consists of three pillars. We have Sleep Cycle AB, 1.4 million monthly active users and around 605,000 paying subscribers. We have Apnea Alert, a contactless sleep apnea risk detector planned to launch in the EU and UK in early 2027 under MDR Class I, and already more than 150,000 people have registered interest. And finally, we have tech licensing that provides sleep tracking for partners, apps, and hardware. And it's the fastest growing part of Sleep Cycle right now, representing 20% of our total revenue. But underneath all of these three pillars is the same shared technology platform powered by our patented sound-based AI model, trained on a massive proprietary data set and needing nothing more than a microphone. No ring, no watch. Just your phone. Next, I want to give you the current status of our pillars, starting with the Sleep Cycle app. We are now seeing the effects of our price increases with 2% improved ARPU on renewals. They remain stable, which highlights the strong stickiness in our product. However, new sales remain weak, with a 24% decrease in paying subscribers year-over-year, mainly due to falling organic traffic. Our focus going forward is to bend that curve, and we want to do that by introducing a new customer onboarding process that demonstrates value early to the customer coming in. We optimize the paywalls and offer new win-back offers, and we are closely collaborating with Apple to ensure good experiences on the new iOS devices now being launched. Next up, Apnea Alert. Now with Apnea Alert, I think we are doing something very special. We are bringing low-friction, contactless sleep apnea risk detection to the masses. Our goal here is to make it as easy as downloading an app. So if you are worried that you suffer from sleep apnea, all you need is your phone and one night of sleep, and in the morning, you will know. But why is this so important? An estimated 1 billion people have sleep apnea worldwide, and around 80% of those are undiagnosed. They suffer from several effects, including excessive daytime fatigue, impaired memory, lack of concentration, and reduced cognitive performance. And they have an increased risk of cardiovascular disease and type 2 diabetes. We estimate that the total addressable market for this is around 25 billion USD. Seeking diagnosis today relies on sleep labs with referrals, overnight sensors, and long waiting lists, or it relies on wearables, which only reach people who already own and wear the device when they sleep. The effect of this is that those 80% remain undiagnosed. Most cases are never found. Apnea Alert needs one night with an iPhone on your bedside table, and we aim to reach people who have never been tested today. The launch plan is early next year. We will launch in the EU and the UK under MDR Class I, and the next step is going to be MDR Class IIa in the EU and FDA submission for the US. Finally, the third pillar is tech licensing. We will license our sleep analysis as an SDK so that our partners can build contactless sleep and breathing measurements into their own apps, devices, and hardware. It only needs a microphone and is built on the same patented technology we use in our app and in Apnea Alert. We have added partners in four different segments in wearables. Ultrahuman converted its pilot into a commercial SDK license in digital health. We signed the Ant Group, our entry into China, and in smart home, Moera launched its mattress with our analysis running directly on their hardware without a phone. Finally, we are doing things in public health as well. We finalized a joint research program with the UKHSA, the UK Health Security Agency, and it showed that our cough data can provide an early warning detection system to identify flu and COVID-19 waves in the UK. And we are now discussing a commercial pilot with the UKHSA. Taking all of this together, this progress is exactly why we have seen record numbers in our B2B business area this quarter. That brings me to the organization. In September, we introduced a more AI-driven way of working with fewer decision levels and smaller teams that own their own results. Three things have truly changed. We are now AI-first, completely AI-first. We build it into how we develop, how we analyze, and how we operate the business. And the roles have become broader. So very small teams, sometimes one person can own their own results end-to-end, which eliminates costly handovers between individuals. Finally, decisions are much faster because there are fewer levels between the decision and the work being done, and we have realized significant gains. Well, we have annual savings of around 35 million SEK, with large effect already in the fourth quarter. But I think even more importantly, we are already seeing very good results and a higher pace in getting development into the hands of our users. We are slimmer, more focused, and we have a clearer path to profitable growth. And that makes us ready for the next chapter. The proposed acquisition of Audiowell is an independent record label and music publisher for sleep and relaxation music, founded in Stockholm in 2013. The idea behind the acquisition is quite simple: Sleep Cycle's sleep analysis and user base. Combined with Audiowell’s music catalogue, it widens our offer from sleep to wellbeing. It adds additional revenue streams in apps and streaming, and in white-label solutions, and with clear synergies between music streaming and Sleep Cycle's popular sleep aid feature. And as a group, it lets us tailor content to each user and launch faster. To give you an idea of the size of the combined business, the 2025 numbers are going to be 625 million SEK in net sales. It was 282 million in EBIT and a 45% profit margin. The acquisition will be paid in Sleep Cycle AB shares. Shareholders will vote at the EGM on the 11th of November, and we expect closing in the fourth quarter. If the deal goes through, Audiowell CEO Gustav Forssell is intended as CEO of the group, and I will take the role of CTO in the new group. With that, I hand over to Elisabeth.

Elisabeth Hedman
10:36 - 16:26

Thank you, Mikael. Let me start with the big picture. This was a quarter of change and, underneath it, the profitability is in good shape. Our top line is still under pressure, with net sales falling 12%, FX-adj. And the reason is the one Mikael Kågebäck described. We are bringing in fewer new subscribers, mainly through the App Store. The customers we bring in, however, are worth more to us at the same exchange rates as last year. ARPU rose by 5% to 262 SEK. 82 from two. 6.9%. Price increases are holding. Renewal rates are stable, and B2B is becoming a real second leg. It is now almost 20% of the revenue, against about 5% two years ago. Reported EBIT looks weak this quarter because it carries 14 million SEK in one-off costs for the CEO exchange and the reorganization that Mikael Kågebäck mentioned as well. Excluding those, the adjusted margin was close to 30%, higher than a year ago. That shows the strong underlying profitability of the business, even with lower revenue. And this is before the organizational changes take effect. The new organization saves around 35 million SEK a year starting in Q4, with full effect from Q1. We also keep investing for growth. The liquidity went down over the year, mainly because we are investing in sleep apnea with our product Apnea Alert and our SDK, and all of this is funded with our own cash. So I will go through the details on the next slide. The next slide, the reported EBIT is 1.1 million. And the adjusted EBIT is 15.1 million, corresponding to a margin of 29.7%. So the gap between the reported and adjusted EBIT this quarter is almost entirely due to the CEO change and the reorganization, plus a small amount for the public offer in Q2. And these costs are now fully taken, and nothing carries over into Q4. In Q4, we will instead expect one-off costs related to the proposed acquisition of Audiowell as items affecting comparability. Let me go one level deeper into the quarter. So the revenue story is the one you have already heard. Consumer sales are down because fewer new subscribers are coming in, while B2B is growing fast. B2B revenue is up almost 50%. I think the cost story is more interesting. Personnel expenses look high at 24.7 million SEK. But more than half of that, 13.4 million SEK, is the one-off cost for the CEO. Change and reorganization. Strip that out. And personnel costs were 11.2 million SEK, almost a fifth lower than a year ago. We have also been more careful with money elsewhere. Marketing is down by about a third, and that's a deliberate choice. We want to fix the onboarding first so that more users that we bring in become paying subscribers, and then every marketing krona works harder when we step up again. So the total other external costs are down 8% on an adjusted basis. The business is spending less and earning a higher margin even on lower sales. And that is why the adjusted EBIT went up from 27% to almost 30%. Looking at the first nine months gives us a fair picture of a year in transition. Sales are down by 14% FX-adj for the same reason as in the quarter. B2B has grown 40%, is now a sixth of the revenue, up from less than a 10th a year ago. Even excluding one-offs, personnel and external costs are higher than last year, and that reflects the first half of the year before we reorganized, with the savings from the new organization only starting in Q4. So you do not see them in these numbers yet. The one-off costs so far this year total about 25 million SEK related to the CEO change, reorganization, and the public offer. Excluding them, the adjusted margin for the nine months is 16%. At the same time, we are investing for the future. We have capitalized around 35 MSEK of development this year, mainly for Apnea Alert, but also for the SDK. So where does this take us? The chart shows the adjusted margin quarter by quarter. After a weak first half, Q3 came in close to 30%, helped by less marketing, fewer consultants, and record-high B2B revenue. The new organization is starting to work for us. We have reduced the organization by around 15 positions and terminated several consultancy contracts and external services. That saves around 35 million a year, with a clear effect already seen in Q4. Full effect from Q4 and onwards. Sorry, that is why we expect an adjusted EBIT margin of around 20% for the full year. We are at 16% for the first nine months, so that means that Q4 should come in around 30%, in line with Q3; including the one-offs we have taken this year, about 25 MSEK, the reported margin lands at around 7%. The outlook covers our current business. It does not include the proposed Audiowell acquisition or its transaction costs. Those will be reported separately as items affecting comparability. So we go into 2027 with a lower cost base, a growing B2B business, and a new product on the way with Apnea Alert. And with that, I'll hand back over to you, Mikael.

Mikael Kågebäck
16:27 - 17:09

Thank you. Elisabeth. All right. So to sum up, before we take questions, the B2C business remains under pressure while the B2B revenue is continuing to grow and reached a record 10 million SEK this quarter, almost 20% of the total revenue. Apnea Alert is now planned to launch in the EU and the UK in early 2027. We launched a new, more efficient organization that saves around 35 million SEK a year starting in Q4, and shareholders will vote on the Audiowell acquisition at the AGM on the 11th of November. With that, we are ready to take questions.

Elisabeth Hedman
17:11 - 19:35

Okay. So we have one question from Jessica Grünwald at Redeye. How sustainable is the margin? Since we said that adjusted EBIT margin was close to 30% in Q3 before the 35 million SEK savings have kicked in, how much of the improvement versus last year comes from ended consultant engagements and lower marketing, and how much comes from higher capitalization of development costs? And should we expect the 35 million to flow through the margins in 2027, or will part of it be reinvested? We will not give a prognosis or forecast of the margin, but what we can say is that the effects took place late in September. But the summer is always a time where our costs are a bit lower due to seasonality, and so you should expect a margin around 30% in Q4 as well. Let us see what is in store for us in 2027 when we have our Apnea Alert product likely bringing in some new revenue. As for the capitalization costs, most of the capitalized costs are related to the clinical studies. There are smaller amounts related to staff, but that is not the big picture. Then we have one more question. What is behind the B2B record? As we said, that was the main driver of the record B2B quarter. Is that revenue recurring per unit or per user, or was there an upfront or one-off element in Q3? How should we think about the B2B run rate going into Q4 and 2027? I can answer that as well. So, where there is recurring revenue, it is a multi-year contract. Basically, we can expect the same revenue from Moera during this period. Some of the other customers are on shorter, one-year contracts. But we are hoping to add new customers going into 2027, but we will not give a forecast on what to expect next year. That concludes the questions we have. So, let's say thank you and goodbye.

Mikael Kågebäck
19:36 - 19:37

Thank you very much.

Continue to the webcast
Lundbeck - Præsentation af delårsrapport for Q3 2026
Language: Danish11/12/2026, 12:00 PM
H. Lundbeck A/S ventes at offentliggøre sin delårsrapport for Q3 2026 den 11. november 2026. Dagen efter, den 12. november kl. 13.00, vil Jens Høyer, Vice President & Head of Investor Relations, præsentere resultaterne og svare på spørgsmål fra publikum i et live online event.
Wirtek - Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 10:00 AM
Wirtek is expected to release its Q3 2026 interim report on 11 November 2026. The next day at 11.00 CET, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session.
Rovsing - Præsentation af Interim Management Statement for Q1 2026/27
Language: Danish11/11/2026, 12:00 PM
Rovsing ventes at offentliggøre sin Interim Management Statement for Q1 2026/27 den 10. november 2026. Den 11. november kl. 13.00 vil ledelsen præsentere kvartalets tal, give en status på udviklingen i forretningen samt følge op på de seneste selskabsnyheder. Præsentationen efterfølges af en Q&A-session.
DADC - Præsentation af handelsopdatering for Q3 2026
Language: Danish11/5/2026, 8:30 AM
Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen. Danish Aerospace and Defence Company (DADC) ventes at offentliggøre sin handelsopdatering for 3. kvartal 2026 den 4. november 2026. Dagen efter, den 5. november kl. 09.30, vil selskabets CEO, Thomas A.E. Andersen, præsentere resultaterne samt svare på spørgsmål i et online live-event.
Boozt AB, Audiocast, Q3'26
Language: English11/3/2026, 8:30 AM
Herman Landin Thank you and good morning to all. Welcome to our Q3 2026 presentation. So, let's turn to the first slide, please. We will follow our usual agenda. I'll take you through the highlights a…
NORDEN – Presentation of Q3 2026
Language: English10/29/2026, 9:30 AM
NORDEN is expected to release its Q3 2026 results on 29th October 2026. The same day at 10.30am, management will present the results in an online event followed by a Q&A.
Agillic – Præsentation af kvartalsrapporten for Q3 2026
Language: Danish10/22/2026, 8:00 AM
Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen. Agillic offentliggør kvartalsrapporten for Q3 2026 den 22. oktober 2026. Samme dag kl. 10:00 vil selskabets CEO Christian Samsø præsentere resultaterne, gennemgå forventningerne til resten af 2026, give en opdatering på markedsforholdene og besvare spørgsmål ved et online live-event.
Nordea third-quarter results 2026
Language: English10/15/2026, 8:00 AM
Head of Investor Relations Good morning and welcome to Nordea's third-quarter 2026 results. Nordea's third-quarter 2026 results. I am your Head of Investor Relations. As usual, we will start with the…
GreenMobility - Presentation of the Q3 2026 Trading Statement
Language: English10/14/2026, 11:00 AM
GreenMobility is expected to release its Q3 2026 Trading Statement on 8 October 2026. On 14 October at 13:00 CEST, CEO Kasper Gjedsted will present the figures and answer questions in a live online event.
Rovsing – Præsentation af årsrapport 2025/26
Language: Danish9/28/2026, 9:00 AM
Rovsing ventes at offentliggøre årsrapporten for regnskabsåret 2025/26 den 25. september 2026. Den 28. september kl. 11.00 vil ledelsen præsentere årets resultater, give en status på udviklingen i forretningen samt kigge frem mod 2026/27. Præsentationen efterfølges af en Q&A-session
Danish Aerospace and Defence Company – Præsentation af H1 2026 resultater
Language: Danish8/25/2026, 8:00 AM
Danish Aerospace and Defence Company (DADC) ventes at offentliggøre selskabets rapport for H1 2026 den 24. august 2026. Dagen efter, den 25. august kl. 10.00, vil selskabets CEO, Thomas A.E. Andersen, præsentere resultaterne samt svare på spørgsmål i et online live-event.
North Media – Præsentation af regnskabet for 2. kvartal 2026
Language: Danish8/21/2026, 12:00 PM
Tilmeld dig North Media’s præsentation af regnskabet for 2. kvartal 2026 – fredag d. 21. august 2026 kl. 14.00. Se med når ledelsen i North Media gennemgår kvartalsregnskabet der offentliggøres dagen før, og hvordan første halvår af 2026 er forløbet, samt svarer på spørgsmål.
Wirtek – Presentation of Q2 2026 Interim Report
Language: English8/14/2026, 9:00 AM
Wirtek is expected to release its Q2 2026 interim report on 12 August 2026. Friday 14 August at 11.00 CEST, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session.
Boozt AB, Audiocast, Q2'26
Language: English8/14/2026, 7:30 AM
Herman Thank you. Good morning to all, and welcome to our Q2 2026 webcast. So let's turn to the first slide, the agenda for today's presentation. We will follow our usual agenda. I'll take you through…
NORDEN – Presentation of the quarterly report for Q2 2026
Language: English8/13/2026, 8:30 AM
NORDEN is set to release its quarterly report for Q2 2026 on the morning of Thursday 13 August 2026. On the same day at 10:30 AM, we are pleased to invite you to a presentation of the financial results with CEO Jan Rindbo and CFO Martin Badsted, who will also answer questions from the audience.
Sampo Oyj, Audiocast, Q2'26
Language: English8/12/2026, 7:30 AM
Mirko Hurmerinta Good morning, everyone, and welcome to Sampo Group's conference call on second quarter 2026 results. My name is Mirko Hurmerinta, the interim Head of IR at Sampo. I am joined on the c…
Nordea half-year results 2026 webcast
Language: English7/16/2026, 8:00 AM
Ilkka Good morning and welcome to Nordea's second quarter 2026 results. I am Ilkka, Head of Investor Relations. As usual, we'll start with the presentation by Group CEO Frank Vang-Jensen, followed by…
NORDEN – Presentation of the quarterly report for Q1 2026
Language: Danish5/6/2026, 8:30 AM
NORDEN is set to release their quarterly report for Q1 2026 on the morning of Wednesday 6 May 2026. On the same day at 10:30 AM, we are pleased to invite you to a presentation of the financial results with CEO Jan Rindbo and CFO Martin Badsted, who will also answer questions from the audience.
Sampo Oyj, Audiocast, Q1'26
Language: English5/6/2026, 7:30 AM
Mirko Hurmerinta Good morning, everyone, and welcome to Sampo Group's conference call on first quarter 2026 results. My name is Mirko Hurmerinta and I am the interim Head of Investor Relations at Samp…
Boozt AB, Audiocast, Q1'26
Language: English4/24/2026, 7:30 AM
Herman Good morning and welcome to our presentation of our Q1 2026 report. Let's just go to the agenda slide. We will have the usual agenda for the presentation. And I will present the highlights of t…